In a blog posted on the Hims & Hers website, the company acknowledged it initially prioritized access to non-GLP-1 treatments but notes that its become clear that GLP-1 drugs will remain in shortage and that this is placing an immense strain on Americans struggling with obesity
Quality concerns have followed too by July 2026, multiple Indian semaglutide manufacturers had recalled batches or delayed supply over quality issues, even as generics came to dominate the market (India Today, July 2026)
For laboratory use, it may be reconstituted with bacteriostatic water or another suitable solvent following standard protocols
risks include gastrointestinal effects, overlapping hepatic metabolism, injection site reactions, and hypoglycaemia, with urgent review required for severe abdominal pain, jaundice, or signs of dehydration
The studies did show harmful effects in pregnant animals and their fetuses when Linzess was given in very high doses